As per the report titled ‘Global Pyrogen Testing Market Size study, by Application (Pharmaceuticals and Biologicals Manufacturing, Medicals Devices Manufacturing, Other Applications) By Product (Kits and Reagents, Services, Instruments) By TEST (LAL Test, In Vitro Pyrogen Test, Rabbit Test) and Regional Forecasts 2019-2026’, available with Market Study Report, global pyrogen testing market was worth USD 758.4 million in 2018 and is projected to record a healthy CAGR of 11.50% during 2019-2026.
 

Pyrogen testing is an analysis process which detects the presence of bacterial toxins in vaccines, drugs, and biotechnological products, that might induce sickness in humans. This testing also aids in monitoring the existence of microbes and their metabolites in drugs and vaccines throughout the manufacturing process to prevent infection and ensure non-appearance of toxic molecular products.
 

Amplification of pharmaceutical and biotechnology industries in tandem with rising incidences of chronic diseases and subsequent economic burden are among the major growth drivers of global pyrogen testing market. Increasing number of new drug launches and growing R&D investments in life sciences industry will foster the market growth in the coming years.
 

Moreover, growing focus towards pharmaceutical outsourcing is anticipated to present lucrative growth opportunities. On the contrary, high degree of consolidation will impede the market growth during the forecast period.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2496543/
 

Based on the product, the market is split into services, kits & reagents, and instruments. On the basis of test, pyrogen testing market is divided into LAL test, In-vitro pyrogen test, and rabbit test. While speaking of the application spectrum, the industry is classified into pharmaceuticals & biologicals manufacturing, medical device manufacturing, and others.
 

As per the regional analysis, pyrogen testing market in North America is anticipated to remunerative growth trends over the forecast timeline. Growing government support, well-established healthcare infrastructure, and presence of large biotechnological firms are supporting the industry growth in North America.
 

Asia-Pacific pyrogen testing market is also expected to accrue significant revenue share during the projection period, owing to favorable government regulations for drug development and increasing healthcare expenditure in the region.
 

Key players in global pyrogen testing market are Wako Chemicals USA, Inc., Merck KGaA, GenScript Biotech, Lonza Group, Ellab A/S, Charles River Laboratories, Inc., WuXi PharmaTech (Cayman) Inc., Hyglos GmbH, Thermo Fisher Scientific, Inc.,  and Cape Cod, Inc.